Tachykinin (NK1, NK2 and NK3) receptor, transient receptor potential vanilloid 1 (TRPV1) and early transcription factor, cFOS, mRNA expression in rat tissues following systemic capsaicin treatment

Regulatory Peptides

Volumn 183, Issue 1, 2013, Pages 35-41

  Kunde, Dale A ^a   Crawford, Amanda ^a   Geraghty, Dominic P ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Capsaicin; MRNA; QPCR; Tachykinin receptors; Transient receptor potential vanilloid 1

Indexed keywords

CAPSAICIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; PROTEIN C FOS; VANILLOID RECEPTOR 1; TACHYKININ RECEPTOR; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; BLOOD; CERVICAL SPINAL CORD; CFOS GENE; COMPARATIVE STUDY; CONTROLLED STUDY; DESENSITIZATION; DRUG MECHANISM; FRONTAL CORTEX; GAPDH GENE; GENE EXPRESSION; MALE; NK1 GENE; NK2 GENE; NK3 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SALIVARY GLAND; STOMACH FUNDUS; TRPV1 GENE; ANIMAL; ANTIBODY SPECIFICITY; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION; WISTAR RAT;

CAPSICUM ANNUUM VAR. ANNUUM; RATTUS;

ANIMALS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; INJECTIONS, SUBCUTANEOUS; MALE; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, TACHYKININ; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC; TRPV CATION CHANNELS;

EID: 84875780061     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.03.001     Document Type: Article

References (42)

1. Gibson S.J., Bloom S.R., Polak J.M. A novel substance P pathway linking the dorsal and ventral horn in the upper lumbar segments of the rat spinal cord. Brain Res 1984, 301:243-251.
2. Maggio J.E. Tachykinins. Annu Rev Neurosci 1988, 11:13-28.
3. Almeida T.A., Rojo J., Nieto P.M., Pinto F.M., Hernandez M., Martin J.D., Candenas M.L. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 2004, 11:2045-2081.
4. Metwali A., Blum A.M., Elliott D.E., Setiawan T., Weinstock J.V. Cutting edge: hemokinin has substance P-like function and expression in inflammation. J Immunol 2004, 172:6528-6532.
5. Zhang Y., Lu L., Furlonger C., Wu G.E., Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat Immunol 2000, 1:392-397.
6. Szallasi A., Cruz F., Geppetti P. TRPV1: a therapeutic target for novel analgesic drugs?. Trends Mol Med 2006, 12:545-554.
7. Richardson J.D., Vasko M.R. Cellular mechanisms of neurogenic inflammation. J Pharmacol Exp Ther 2002, 302:839-845.
8. Brain S.D. Sensory neuropeptides: their role in inflammation and wound healing. Immunopharmacology 1997, 37:133-152.
9. Szolcsanyi J. Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism. Prog Brain Res 1996, 113:343-359.
10. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988, 24:739-768.
11. Caterina M.J., Leffler A., Malmberg A.B., Martin W.J., Trafton J., Petersen-Zeitz K.R., Koltzenburg M., Basbaum A.I., Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000, 288:306-313.
12. Szallasi A., Blumberg P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999, 51:159-212.
13. Dussor G.O., Helesic G., Hargreaves K.M., Flores C.M. Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron. Pain 2004, 107:22-32.
14. Haxhiu M.A., Yamamoto B., Dreshaj I.A., Bedol D., Ferguson D.G. Involvement of glutamate in transmission of afferent constrictive inputs from the airways to the nucleus tractus solitarius in ferrets. J Auton Nerv Syst 2000, 80:22-30.
15. Chiu R., Boyle W.J., Meek J., Smeal T., Hunter T., Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988, 54:541-552.
16. Bakin A.V., Curran T. Role of DNA 5-methylcytosine transferase in cell transformation by fos. Science 1999, 283:387-390.
17. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
18. Buck S.H., Burcher E., Shults C.W., Lovenberg W., O'Donohue T.L. Novel pharmacology of substance K-binding sites: a third type of tachykinin receptor. Science 1984, 226:987-989.
19. Buck S.H., Helke C.J., Burcher E., Shults C.W., O'Donohue T.L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides 1986, 7:1109-1120.
20. Walker P.R., Smith B., Liu Q.Y., Famili A.F., Valdes J.J., Liu Z., Lach B. Data mining of gene expression changes in Alzheimer brain. Artif Intell Med 2004, 31:137-154.
21. Burcher E., Buck S.H. Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder. Eur J Pharmacol 1986, 128:165-177.
22. Portbury A.L., Furness J.B., Southwell B.R., Wong H., Walsh J.H., Bunnett N.W. Distribution of neurokinin-2 receptors in the guinea-pig gastrointestinal tract. Cell Tissue Res 1996, 286:281-292.
23. Jaafari N., Khomitch-Baud A., Christen M.O., Jule Y. Distribution pattern of tachykinin NK2 receptors in human colon: involvement in the regulation of intestinal motility. J Comp Neurol 2007, 503:381-391.
24. Saunders C.I., Fassett R.G., Geraghty D.P. Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death. Biochim Biophys Acta 2009, 1792:1019-1026.
25. Saunders C.I., Kunde D.A., Crawford A., Geraghty D.P. Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. Mol Immunol 2007, 44:1429-1435.
26. Jancso G., Kiraly E., Joo F., Such G., Nagy A. Selective degeneration by capsaicin of a subpopulation of primary sensory neurons in the adult rat. Neurosci Lett 1985, 59:209-214.
27. Geraghty D.P., Mazzone S.B. Tachykinin receptor (NK(1), NK(2), NK(3)) binding sites in the rat caudal brainstem following neonatal capsaicin administration. Brain Res 2003, 979:230-234.
28. Zhang Y.Y., Zhu W.X., Cao G.H., Cui X.Y., Ai H.B. c-Fos expression in the supraoptic nucleus is the most intense during different durations of restraint water-immersion stress in the rat. J Physiol Sci 2009, 59:367-375.
29. Mehiri S.N., Barreiro E., Hayot M., Voyer M., Comtois A.S., Grassino A.E., Czaika G. Time-based gene expression programme following diaphragm injury in a rat model. Eur Respir J 2005, 25:422-430.
30. Heng Y.J., Saunders C.I., Kunde D.A., Geraghty D.P. TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration. Regul Pept 2011, 167:250-258.
31. Geraghty D.P., Burcher E. Effect of chronic capsaicin treatment on tachykinin NK1 binding sites in the rat. Peptides 1992, 13:409-411.
32. Zvara A., Bencsik P., Fodor G., Csont T., Hackler L., Dux M., Furst S., Jancso G., Puskas L.G., Ferdinandy P. Capsaicin-sensitive sensory neurons regulate myocardial function and gene expression pattern of rat hearts: a DNA microarray study. FASEB J 2006, 20:160-162.
33. Holzer P., Painsipp E., Schuligoi R. Differential effects of intragastric acid and capsaicin on gastric emptying and afferent input to the rat spinal cord and brainstem. BMC Neurosci 2005, 6:60.
34. Lai J.P., Douglas S.D., Ho W.Z. Human lymphocytes express substance P and its receptor. J Neuroimmunol 1998, 86:80-86.
35. Brunelleschi S., Bordin G., Colangelo D., Viano I. Tachykinin receptors on human monocytes: their involvement in rheumatoid arthritis. Neuropeptides 1998, 32:215-223.
36. Brunelleschi S., Vanni L., Ledda F., Giotti A., Maggi C.A., Fantozzi R. Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors. Br J Pharmacol 1990, 100:417-420.
37. Mezey E., Toth Z.E., Cortright D.N., Arzubi M.K., Krause J.E., Elde R., Guo A., Blumberg P.M., Szallasi A. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc Natl Acad Sci USA 2000, 97:3655-3660.
38. Geraghty D.P., Mazzone S.B. Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide. Br J Pharmacol 2002, 137:919-927.
39. Mazzone S.B., Geraghty D.P. Characterization and regulation of tachykinin receptors in the nucleus tractus solitarius. Clin Exp Pharmacol Physiol 2000, 27:939-942.
40. Mazzone S.B., Geraghty D.P. Respiratory actions of tachykinins in the nucleus of the solitary tract: characterization of receptors using selective agonists and antagonists. Br J Pharmacol 2000, 129:1121-1131.
41. Cavanaugh D.J., Chesler A.T., Jackson A.C., Sigal Y.M., Yamanaka H., Grant R., O'Donnell D., Nicoll R.A., Shah N.M., Julius D., Basbaum A.I. Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci 2011, 31:5067-5077.
42. Birder L.A., Kanai A.J., de Groat W.C., Kiss S., Nealen M.L., Burke N.E., Dineley K.E., Watkins S., Reynolds I.J., Caterina M.J. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001, 98:13396-13401.